Patent US4507415A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4507415A Expired / Lapsed US ⏱️ 0.0 years remaining

Medical articles

Assignee: Terumo Corp
•
Filing: 1983-03-23
•
Granted: 1985-03-26
•
Expires: 2003-03-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Irradiation-sterilizable medical articles molded from a propylene polymer composition in which stabilizers are incorporated. Said composition comprises from 0.01 to 0.4 part by weight of each of a specific hindered amine and a specific phenol or its phosphite ester compound incorporated per 100 parts by weight of a propylene polymer with a weight-average molecular-weight to number-average molecular-weight ratio of 5 or below. The above-mentioned composition may additionally contain a sorbitol derivative as the nucleating agent. Medical articles produced from said composition by molding, for example, syringes are suitable for irradiation sterilization. Said medical articles when irradiated undergo little reduction in quality of the material and are accompanied by little bleeding or degradation of the incorporated stabilizers and nucleating agent.

Inventors

  • 👤 Masaaki Kasai
  • 👤 Toshiji Ichikawa
  • 👤 Kimiho Kosegaki

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 12:34
CPC Classifications
C; C08; C08K; C08K5/00; C08K5/16; C08K5/34; C08K5/3467; C08K5/3477; A; A61; A61L; A61L2/00; A61L2/02; A61L2/08; C08K5/04; C08K5/13; C08K5/3412; C08K5/3415; C08K5/3432; C08K5/3435; C08K5/49; C08K5/51; C08K5/52; C08K5/524; C08K5/526

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 179 words
An irradiation-sterilizable medical article molded from a composition comprising as the stabilizers from 0.01 to 0.4 part by weight of a hindered amine represented by the formula [I] or [II] below and from 0.01 to 0.4 part by weight of a phenol or its phosphite ester compound represented by the formula [III], or [V] below per 100 parts by weight of a propylene polymer with a weight-average molecular-weight to number-average molecular-weight ratio of 5 or below. ##STR5## wherein: R 1 represents an alkyl group containing 1-12 carbon atoms; R 2 represents an alkyl group containing 3-12 carbon atoms; R 3 represents an alkyl group containing 1-18 carbon atoms; X represents hydrogen atom or the group ##STR6## in which R 4 is an alkyl group containing 1-30 carbon atoms; Y represents a divalent hydrocarbon radical containing 1-18 carbon atoms or sulfur atom; P1 Z represents a divalent hydrocarbon radical containing 1-8 carbon atoms in which a carbonyloxy group may be interposed; k is an integer of 1-10; l is an integer of 1-16; and m is an integer of 1-6.
Claim 2
Dependent Claim 179 words
An irradiation-sterilizable medical article molded from a composition comprising as the stabilizers from 0.01 to 0.4 part by weight of a hindered amine represented by the formula [I] or [II] below and from 0.01 to 0.4 part by weight of a phenol or its phosphite ester compound represented by the formula [III], or [V] below per 100 parts by weight of a propylene polymer with a weight-average molecular-weight to number-average molecular-weight ratio of 5 or below. ##STR5## wherein: R 1 represents an alkyl group containing 1-12 carbon atoms; R 2 represents an alkyl group containing 3-12 carbon atoms; R 3 represents an alkyl group containing 1-18 carbon atoms; X represents hydrogen atom or the group ##STR6## in which R 4 is an alkyl group containing 1-30 carbon atoms; Y represents a divalent hydrocarbon radical containing 1-18 carbon atoms or sulfur atom; P1 Z represents a divalent hydrocarbon radical containing 1-8 carbon atoms in which a carbonyloxy group may be interposed; k is an integer of 1-10; l is an integer of 1-16; and m is an integer of 1-6.
Claim 3
Dependent Claim 78 words
A medical article according to claim 1 molded from a composition comprising as the stabilizers from 0.03 to 0.3 part by weight of a hindered amine represented by the aforementioned formula [I] or [II] and from 0.02 to 0.2 part by weight of a phenol or its phosphite ester compound represented by the aforementioned formula [III], or [V] per 100 parts by weight of a propylene polymer with a weight-average molecular-weight to number average molecular-weight ratio of 2.5-4.8.
Claim 4
Dependent Claim 33 words
A medical article according to claim 1 or 2 wherein said hindered amine is a compound represented by said formula [I] in which R 1 is methyl and k is 3 or 4.
Claim 5
Dependent Claim 31 words
A medical article according to claim 1 or 2 wherein said hindered amine is a compound represented by said formula [II] in which R 1 is methyl and l is 2.
Claim 6
Dependent Claim 39 words
A medical article according to claim 1 wherein said phenol compound is a compound represented by said formula [III] in which R 2 is t-butyl (5-position), R 3 is methyl (2-position), X is hydrogen atom and m is 1.
Claim 7
Dependent Claim 45 words
A medical article according to claim 1 wherein said phenol phosphite ester compound is a compound represented by said formula [III] in which R 2 is t-butyl (5-positon), R 3 is methyl, X is the group--P(OC 18 H 37 ) 2 and m is 1.
Claim 8
Dependent Claim 36 words
A medical article according to claim 1 wherein said phenol compound is a compound represented by said formula [V] in which R 2 and R 3 each are t-butyl (3- and 5-positions) and Z is methylene.
Claim 9
Dependent Claim 14 words
A medical article according to claim 1 wherein said molded articles are injection-molded products.
Claim 10
Dependent Claim 28 words
A medical article according to claim 8 wherein said injection-molded products are syringes, needle bases for the syringe, infusion or blood transfusion set or instruments for blood collection.
Claim 11
Dependent Claim 79 words
A medical article according to claim 1 molded from a composition additionally containing from 0.01 to 0.4 part by weight of a compound represented by the formula [VI] below as the nucleating agent in said composition. ##STR7## in which R 5 and R 6 each represent an alkyl or alkoxy group containing 1-8 carbon atoms, hydroxyl group or a halogen atom, n 1 and n 2 each independently represent an integer of 1-3 and p represents 0 or 1.
Claim 12
Dependent Claim 32 words
A medical article according to claim 10 molded from a composition additionally containing from 0.05 to 0.3 part by weight of a compound represented by said formula [VI] as the nucleating agent.
Claim 13
Dependent Claim 43 words
A medical article according to claims 10 or 11 wherein said nucleating agent is a compound of said formula [VI] in which R 5 and R 6 each are methyl (4-position), n 1 and n 2 each are 1 and p is 1.
Claim 14
Dependent Claim 112 words
A medical article according to claim 2 wherein said hindered amine is a compound represented by said formula [I] in which R 1 is methyl and k is 3 or 4 or a compound represented by said formula [II] in which R 1 is methyl and l is 2; and said phenol compound is a compound represented by (i) said formula [III] in which R 2 is t-butyl (5-position), R 3 is methyl (2-position), X is hydrogen atom and m is 1 or (ii) said formula [III] in which R 2 is t-butyl (5-position), R 3 is methyl, X is the group --P(OC 18 H 37 ) 2 and m is 1.
Claim 15
Dependent Claim 79 words
A medical article according to claim 13 molded from a composition additionally containing from 0.01 to 0.4 part by weight of a compound represented by the formula (VI) below as the nucleating agent in said composition ##STR8## in which R 5 and R 6 each represent an alkyl or alkoxy group containing 1-8 carbon atoms, hydroxyl group or a halogen atom, n 1 and n 2 each independently represent an integer of 1-3 and p represents 0 or 1.
Claim 16
Dependent Claim 78 words
A medical article according to claim 2 wherein said hindered amine is a compound represented by said formula [I] in which R 1 is methyl and k is 3 or 4 or a compound represented by said formula [II] in which R 1 is methyl and l is 2; and said phenol compound is a compound represented by said formula [V] in which R 2 and R 3 each are t-butyl (3- and 5-positions) and Z is methylene.

References Cited (Backward Citations)

US3196185A Cited
US3476699A Cited
US3356770A Cited
US3940325A Cited
US4233412A Cited
US4210577A Cited
US4221700A Cited
EP0007736A1 Cited
US4401536A Cited
US4314039A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-03-25 1988-09-24 1989-03-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-03-25 1992-09-24 1993-03-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-03-25 1996-09-24 1997-03-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag